Progressive coronary aneurysms in Behçet disease, a journey through surgical and percutaneous treatment: A case

Aysha Husain1, Abdalkareem Al-Allaf1, Maha AlAmri1

  • 1Heart Center, King Faisal Hospital and Research Center, Riyadh, Saudi Arabia.

Journal of Cardiology Cases
|December 15, 2018
PubMed

Insights

Behçet disease, a rare autoimmune condition, can cause aggressive coronary aneurysms presenting as acute coronary syndrome. Interventions like bypass surgery and stenting may be necessary despite medical therapy.

Area of Science:

  • Cardiology
  • Rheumatology
  • Vascular Medicine

Background:

  • Behçet disease is a systemic autoimmune disorder characterized by vascular inflammation.
  • Coronary artery involvement, including stenosis, arteritis, and aneurysm formation, is uncommon but can be severe.
  • Standard treatment focuses on systemic immunosuppression with steroids and other medications.

Purpose of the Study:

  • To present a case of Behçet disease presenting with aggressive coronary aneurysms and acute coronary syndrome.
  • To highlight the challenges in managing Behçet disease-related coronary artery pathology.
  • To discuss the role of interventional and surgical approaches in critical cases.

Main Methods:

  • Case report of a 34-year-old male with acute coronary insult.
  • Review of diagnostic findings and clinical course.
  • Description of interventions including bypass graft surgery and percutaneous coronary intervention with cover stents.

Main Results:

  • The patient presented with acute coronary syndrome attributed to Behçet disease.
  • He required emergency bypass graft surgery for a ruptured coronary aneurysm and cardiac tamponade.
  • Despite medical management, he later developed multiple coronary aneurysms necessitating percutaneous intervention with cover stents.

Conclusions:

  • Behçet disease is a rare but significant cause of coronary aneurysms presenting with acute coronary syndrome.
  • Coronary aneurysms in Behçet disease carry a high risk of rupture, requiring aggressive management.
  • Surgical and interventional procedures, such as bypass grafting and cover stents, may be crucial adjuncts to medical therapy with variable outcomes.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
443
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
949
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
372